{"url_path":"/sec/cik-0001852536/8-k/2026-06-22/item-4-02","section_key":"item-4-02","section_title":"Item 4.02 Non-Reliance on Previously Issued Financial","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1852536/0001683168-26-005012-index.html","accession_number":"0001683168-26-005012","cik":"0001852536","ticker":null,"issuer_name":"Redox International Group, Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1852536/0001683168-26-005012-index.html","primary_entity_key":"0001852536","primary_entity_name":"Redox International Group, Corp."},"word_count":657,"has_tables":true,"body_markdown":"**Item 4.02. Non-Reliance on Previously Issued Financial\nStatements or a Related Audit Report or Completed Interim Review.**\n\n** **\n\n(a) On May 30, 2026, the management of Redox International\nGroup, Corp. (formerly Intorio, Corp.) (the “Company”), together with the Board of Directors of the Company, concluded that\nthe Company’s previously issued unaudited interim financial statements for the quarterly periods ended August 31, 2024 and November\n30, 2024 (collectively, the “Affected Periods”), as included in the Company’s Quarterly Reports on Form 10-Q filed with\nthe Securities and Exchange Commission (the “SEC”) on October 31, 2024 and February 19, 2025, respectively, should no longer\nbe relied upon. Accordingly, any previously issued press releases, investor presentations, and other communications describing the Company’s\nfinancial results for the Affected Periods should likewise no longer be relied upon.\n\n \n\nThe determination to restate the financial statements\nfor the Affected Periods arose from the Company’s conclusion that those financial statements did not reflect the issuance of 50,850,000\nshares of the Company’s common stock on June 5, 2024 to certain founders, advisors, and consultants under certain Founder Agreements\nand Advisory Agreements, or the related stock-based compensation required to be recognized under ASC 718, *Compensation—Stock\nCompensation*. As originally filed, the financial statements for each of the quarters ended August 31, 2024 and November 30, 2024 reported\n3,235,000 shares of common stock issued and outstanding and stated that the Company had not issued any stock-based payments, neither of\nwhich reflected the June 5, 2024 issuances. The Company has determined that the compensation cost associated with these share issuances\nmust be measured at the grant-date fair value of the awards and recognized over the applicable requisite service period in accordance\nwith ASC 718.\n\n \n\nAs a result of correcting these errors, the Company\nexpects the restatement to affect, for one or more of the Affected Periods, the following: shares of common stock issued and outstanding;\nweighted-average shares outstanding; stock-based compensation expense; general and administrative expense; net loss; net loss per share;\ncommon stock; additional paid-in capital; and deferred (unearned) stock-based compensation reported within stockholders’ equity,\ntogether with the related subtotals and totals. The restatement is non-cash in nature and is not expected to affect the Company’s\npreviously reported cash, cash equivalents, or total cash flows. The Company is in the process of finalizing the amount of the adjustments,\nwhich remains subject to the completion of the restatement process and the procedures of its independent registered public accounting\nfirm.\n\n \n\nThe Company intends to restate the financial statements\nfor the Affected Periods by filing amended Quarterly Reports on Form 10-Q/A with the SEC as promptly as practicable. Until the amended\nreports are filed, investors and others should not rely on the financial statements and related disclosures for the Affected Periods.\n\n \n\nThe Company does not have a separate audit committee.\nThe Company’s Board of Directors has discussed the matters disclosed in this Item 4.02(a) with the Company’s independent registered\npublic accounting firm, Michael Gillespie & Associates, PLLC.\n\n \n\n**Cautionary Note Regarding Forward-Looking Statements**\n\n** **\n\nThis Current Report on Form 8-K contains forward-looking\nstatements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including\nstatements regarding the anticipated restatement, the expected effects thereof, and the timing of the Company’s amended filings.\nThese statements are based on the Company’s current expectations and are subject to risks and uncertainties that could cause actual\nresults to differ materially, including the completion of the restatement process and the related procedures of the Company’s independent\nregistered public accounting firm. The Company undertakes no obligation to update any forward-looking statement except as required by\nlaw.\n\n \n\n \n\n \n\n \n\n \n\n 2 \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \n**REDOX INTERNATIONAL GROUP, CORP.**\n\n \n \n \n\nDated: June 22, 2026\nBy:\n*/s/ Han-Wen\nOu*\n\n \nName:\nHan-Wen Ou\n\n \nTitle:\nChief Executive Officer and Chief Financial Officer\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n 3"}